Nutrient stress revamps cancer cell metabolism

Jorge Moscat1, Adam Richardson1, Maria T Diaz-Meco1

  • 1Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.

Cell Research
|April 2, 2015
PubMed

Insights

Researchers are exploring new cancer therapeutic targets beyond traditional oncogenes. This alternative strategy focuses on proteins essential for cancer-specific stresses, offering novel treatment avenues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Traditional cancer research focused on oncogenes and tumor suppressor genes.
  • These genes drive cancer development and progression.
  • Understanding their mechanisms is key for targeted therapies.

Purpose of the Study:

  • To explore an alternative strategy for identifying cancer therapeutic targets.
  • To investigate proteins not encoded by oncogenes but crucial for cancer survival.
  • To uncover novel targets accommodating cancer-specific stresses.

Main Methods:

  • Literature review of emerging cancer research strategies.
  • Analysis of protein functions in the context of cellular stress.
  • Identification of non-oncogene-encoded proteins critical for cancer adaptation.

Main Results:

  • An alternative strategy for cancer target identification is emerging.
  • This approach focuses on proteins supporting cancer-specific stresses.
  • These targets are independent of oncogene and tumor suppressor gene pathways.

Conclusions:

  • Targeting proteins essential for cancer-specific stresses offers a new therapeutic avenue.
  • This strategy complements traditional approaches by broadening the scope of druggable targets.
  • Further research into these novel targets could lead to innovative cancer treatments.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.4K